XOMA Royalty (XOMA) Operating Leases (2019 - 2026)
XOMA Royalty (XOMA) reported Operating Leases of $19.5 million for Q1 2026, up 5286.74% on a YoY basis from $362000.0 in Q1 2025, and down 2.99% sequentially from $20.1 million in Q4 2025.
XOMA Royalty (XOMA) Operating Leases (2019 - 2026) Analysis & Trends
XOMA Royalty (XOMA) has 7 years of Operating Leases data on file, last reported at $19.5 million in Q1 2026.
- For the quarter ending Q1 2026, Operating Leases rose 5286.74% year-over-year to $19.5 million; the trailing twelve-month figure through Mar 2026 stood at $19.5 million (up 5286.74% YoY), and the FY2025 full-year result was $20.1 million, up 3920.0% from the prior year.
- Operating Leases eased to $19.5 million in Q1 2026, from $20.1 million in the prior quarter.
- In the past five years, Operating Leases ranged from a high of $20.6 million in Q3 2025 to a low of $200000.0 in Q2 2025.
- A 4-year average of $6.3 million and a median of $550000.0 in 2024 frame the typical range for Operating Leases.
- Across the five-year window, Operating Leases sank 71.43% in 2025 and surged 5286.74% in 2026, its largest moves.
- Tracing XOMA's Operating Leases over 4 years: stood at $335000.0 in 2023, then jumped by 49.25% to $500000.0 in 2024, then jumped by 3920.0% to $20.1 million in 2025, then retreated by 2.99% to $19.5 million in 2026.
- Business Quant data shows XOMA's Operating Leases at $19.5 million in Q1 2026, $20.1 million in Q4 2025, and $20.6 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | XOMA Royalty | 478.42 Mn | 412.34 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 19.50 Mn |
| Dec 31, 2025 | 20.10 Mn |
| Sep 17, 2025 | 20.65 Mn |
| Jun 30, 2025 | 200,000.00 |
| Mar 31, 2025 | 362,000.00 |
| Dec 31, 2024 | 500,000.00 |
| Sep 30, 2024 | 600,000.00 |
| Jun 30, 2024 | 700,000.00 |
| Mar 31, 2024 | 300,000.00 |
| Dec 31, 2023 | 335,000.00 |
| Dec 31, 2021 | 34,000.00 |
| Sep 30, 2021 | 85,000.00 |
| Jun 30, 2021 | 133,000.00 |
| Mar 31, 2021 | 182,000.00 |
| Dec 31, 2020 | 229,000.00 |
| Sep 30, 2020 | 275,000.00 |
| Jun 30, 2020 | 320,000.00 |
| Mar 31, 2020 | 365,000.00 |
| Dec 31, 2019 | 408,000.00 |
| Sep 30, 2019 | 5.19 Mn |